RxDoctor Payments Data

Cynthia Kepfer, APRN

Psychiatric/Mental Health · Vero Beach, FLNPI 1770029597

Payments from drug & device makers

$1,962in general payments, 2019–2025

Across 115 payments — averaging $17.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$737
  • Alkermes, Inc.$197
  • Teva Pharmaceuticals USA, Inc.$173
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$169
  • Otsuka America Pharmaceutical, Inc.$146
  • Johnson & Johnson$120
  • plus $419 from 8 others

What the payments were for

  • Food & beverage$1,962100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,962 in reported general payments places this provider in the 70th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida

Medicare billing

Part B allowed, 2024
$88,495
Medicare patients
191
Services billed
869

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate20$45,631
VraylarCariprazine Hcl25$35,568
Lurasidone Hcl26$13,342
TrintellixVortioxetine Hydrobromide11$8,189
Bupropion XlBupropion Hcl159$4,486
Aripiprazole38$3,196
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine91$2,068
Quetiapine Fumarate92$2,038
Clonazepam238$1,998
Venlafaxine Hcl ErVenlafaxine Hcl79$1,708
Alprazolam233$1,585
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine21$1,412
Escitalopram Oxalate109$1,314
Lamotrigine75$1,306
Fluoxetine Hcl120$1,304

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$120$45,63120 claims
AbbVieVraylar$737$35,56825 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$77$8,18911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,096 psychiatric/mental health providers in Florida.

Other psychiatric/mental health in Vero Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →